FBRX
Companies
NASDAQ
Forte Biosciences Inc.
Health Care
$12.45
-$10.27 (-45.20%)
Price Chart
Overview
About FBRX
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Market Cap
$21.2M
Volume
249.1K
Avg. Volume
314.7K
P/E Ratio
-0.41698632
Dividend Yield
0.00%
Employees
12.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.39
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, FBRX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$21.2M
Volume249.1K
P/E Ratio-0.42
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
August 12, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025